{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["13"],"submitter":["Roux P"],"pubmed_abstract":["<h4>Background</h4>Cocaine use is frequent in patients receiving methadone maintenance treatment (MMT) and can jeopardize their treatment response. Identifying clinical predictors of cocaine use during methadone treatment can potentially improve clinical management. We used longitudinal data from the ANRS Methaville trial both to describe self-reported occasional and regular cocaine use during MMT and to identify clinical predictors.<h4>Methods</h4>We selected 183 patients who had data on cocaine (or crack) use at months 0 (M0), M6, and/or M12, accounting for 483 visits. The outcome was \"cocaine use\" in three categories: \"no,\" \"occasional,\" and \"regular\" use. To identify factors associated with the outcome over time, we performed a mixed multinomial logistic regression.<h4>Results</h4>Time"],"journal":["Harm reduction journal"],"pagination":["12"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4822310"],"repository":["biostudies-literature"],"pubmed_title":["Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study)."],"pmcid":["PMC4822310"],"pubmed_authors":["Carrieri PM","Job-Spira N","Aubertin JF","Marcellin F","Haemmig R","Olivet F","Vilotitch A","Giovannini C","Lions C","Huguet S","Kissikian MP","Beauverie P","Dore V","Richard N","Maradan G","Prisse N","Paul C","Bachellier J","Spire B","Porteret I","Couteron JP","Wodak A","ANRS Methaville study group","Arditti J","Morel A","Mora M","Marty-Double C","Biemar J","Roux P","Herszkowicz A","Catania H","Daulouede JP","Marie T","Michel CL","Vray M","Torrens M","Taieb C","Michel L","Kurkdji P","Robinet S","Cohen J","Gossop M","Desenclos JC","Baker R"],"additional_accession":[]},"is_claimable":false,"name":"Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study).","description":"<h4>Background</h4>Cocaine use is frequent in patients receiving methadone maintenance treatment (MMT) and can jeopardize their treatment response. Identifying clinical predictors of cocaine use during methadone treatment can potentially improve clinical management. We used longitudinal data from the ANRS Methaville trial both to describe self-reported occasional and regular cocaine use during MMT and to identify clinical predictors.<h4>Methods</h4>We selected 183 patients who had data on cocaine (or crack) use at months 0 (M0), M6, and/or M12, accounting for 483 visits. The outcome was \"cocaine use\" in three categories: \"no,\" \"occasional,\" and \"regular\" use. To identify factors associated with the outcome over time, we performed a mixed multinomial logistic regression.<h4>Results</h4>Time","dates":{"release":"2016-01-01T00:00:00Z","publication":"2016 Apr","modification":"2025-04-04T12:39:15.81Z","creation":"2019-03-27T03:11:19Z"},"accession":"S-EPMC4822310","cross_references":{"pubmed":["27048152"],"doi":["10.1186/s12954-016-0100-7"]}}